tradingkey.logo

Brainsway Ltd

BWAY
View Detailed Chart
21.780USD
+0.850+4.06%
Close 02/06, 16:00ETQuotes delayed by 15 min
413.90MMarket Cap
66.07P/E TTM

Brainsway Ltd

21.780
+0.850+4.06%
Intraday
1m
30m
1h
D
W
M
D

Today

+4.06%

5 Days

-6.84%

1 Month

+2.01%

6 Months

+83.95%

Year to Date

+14.51%

1 Year

+104.70%

View Detailed Chart

TradingKey Stock Score of Brainsway Ltd

Currency: USD Updated: 2026-02-06

Key Insights

Brainsway Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 87 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 30.00.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Brainsway Ltd's Score

Industry at a Glance

Industry Ranking
87 / 205
Overall Ranking
236 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Brainsway Ltd Highlights

StrengthsRisks
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 50.92% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 41.02M.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 66.07, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 6.12M shares, increasing 8.58% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 313.16K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.10.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
30.000
Target Price
+43.33%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Brainsway Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Brainsway Ltd Info

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Ticker SymbolBWAY
CompanyBrainsway Ltd
CEOLevy (Hadar)
Websitehttps://www.brainsway.com/
KeyAI